Inhibition of antigen-induced airway hyperresponsiveness by ultralow molecular-weight heparin

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 3 PART I, 1998, Pages 887-893

  Molinari, Jussara F ^a   Campo, Carlos ^a   Shakir, Shahida ^a   Ahmed, Tahir ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBACHOL; HEPARIN;

AIRWAY PRESSURE; ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN FUNCTION; ARTICLE; ASCARIS SUUM; HISTAMINE RELEASE; HYPOTHESIS; LUNG LAVAGE; MAST CELL; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RADIOIMMUNOASSAY; SHEEP;

ADMINISTRATION, INHALATION; AEROSOLS; AIRWAY RESISTANCE; ANIMALS; ANTICOAGULANTS; ANTIGENS, HELMINTH; ASCARIS SUUM; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOCONSTRICTION; CARBACHOL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPARIN, LOW-MOLECULAR-WEIGHT; HISTAMINE; HISTAMINE RELEASE; LUNG; MAST CELLS; MOLECULAR WEIGHT; MUSCARINIC AGONISTS; RESPIRATORY HYPERSENSITIVITY; SHEEP;

EID: 0031922544     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.3.9708027     Document Type: Article

References (36)

1. Jaques, L. B. 1979. Heparins - anionic polyelectrolyte drugs. Pharmacol. Rev. 31:99-166.
2. Lindhardt, R. J., and D. Loganathan. 1990. Heparin, heparinoids and heparin oligosaccharides: structure and biological activities. In Biominetic Polymers. C. G. Gebelein, editor. Plenum Press, New York. 135-173.
3. Lindahl, U. 1989. Biosynthesis of heparin and related polysaccharides. In Heparin, Chemical and Biological Properties, Clinical Applications. D. A. Lane and U. Lindahl, editors. CRC Press, Boca Raton, FL 159-189.
4. Lindahl, U., G. Bäckström, L. Thunberg, and I. G. Leder. 1980. Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc. Natl. Acad. Sci. U.S.A. 77:6551-6555.
5. Ishihara, M., R. Takano, T. Kanda, K. Hayashi, S. Hara, H. Kikuchi, and K. Yoshida. 1995. Importance of 6-O-sulfate groups of glucosamine residues in heparin for activation of FGF-1 and FGF-2. J. Biochem. 118:1255-1260.
6. Burgess, W. H., and T. Maciag. 1989. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58:575-606.
7. 1. J. Cell. Physiol. 152:430-440.
8. Castellot, J. J., Jr., D. L. Cochran, and M. J. Karnovsky. 1985. Effect of heparin on vascular smooth muscle cells: 1. Cell metabolism. J. Cell. Physiol. 124:21-28.
9. Wright, T. C., Jr., T. V. Johnstone, J. J. Castellot, and M. J. Karnovsky. 1985. Inhibition of rat cervical epithelial cell growth by heparin and its reversal by EGF. J. Cell. Physiol. 125:499-506.
10. Folkman, J., and D. E. Ingber. 1989. Angiogenesis: regulatory role of heparin and related molecules. In Heparin. D. A. Lane and U. Lindahl, editors. Edward Arnold, London. 317-333.
11. Schwartz, L. B., and T. R. Bradford. 1986. Regulation of tryptase from human lung mast cells by heparin: stabilization of the active tetramer. J. Biol. Chem. 261:7372-7379.
12. Schwartz, L. B., C. Riedel, J. P. Caulfield, S. I. Wasserman, and K. F. Austen. 1981. Cell association of complexes of chymase, heparin proteoglycan, and protein after degranulation by rat mast cells. J. Immunol. 126:2071-2078.
13. Dolowitz, D. A., and T. F. Dougherty. 1960. The use of heparin as an anti-inflammatory agent. Laryngoscope 70:873-884.
14. Weiler, J. M., R. E. Edens, R. J. Linhardt, and D. P. Kapelanski. 1992. Heparin and modified heparin inhibit complement activation in vivo. J. Immunol. 148:3210-3215.
15. Seeds, E. A. M., J. Hanss, and C. P. Page. 1993. The effect of heparin and related proteoglycans on allergen and PAF-induced eosinophil infiltration. J. Lipid. Mediat. 7:269-278.
16. Lider, O., Y. A. Mekori, T. Miller, R. Bar-Tana, I. Vlodavsky, E. Baharav, I. R. Cohen, and Y. Naparstek. 1990. Inhibition of T-lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity. Eur. J. Immunol. 20:493-499.
17. Matzner, Y., G. Marx, R. Drexler, and A. Eldor. 1984. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis. Thromb. Haemost. 52:134-137.
18. Ahmed, T., W. M. Abraham, and J. D'Brot. 1992. Effects of inhaled heparin on immunologic and non-immunologic bronchoconstrictor responses in sheep. Am. Rev. Respir. Dis. 145:566-570.
19. Ahmed, T., J. Garrigo, and I. Danta. 1993. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N. Engl. J. Med. 329:90-95.
20. Bowler, S. D., S. M. Smith, and P. S. Lavercombe. 1993. Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects. Am. Rev. Respir. Dis. 147:160-163.
21. Diamant, Z., M. C. Timmers, H. van der Veen, C. P. Page, F. J. van der Meer, and P. J. Sterk. 1996. Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. Am. J. Respir. Crit. Care Med. 153:1790-1795.
22. Lucio, J., J. D'Brot, C. B. Guo, W. M. Abraham, L. M. Lichtenstein, A. Kagey-Sobotka, and T. Ahmed. 1992. Immunologic mast cell-mediated responses and histamine release are attenuated by heparin. J. Appl. Physiol. 73:1093-1101.
23. Ahmed, T., T. Syriste, R. Mendelssohn, D. Sorace, E. Mansour, M. Lansing, W. M. Abraham, and M. J. Robinson. 1994. Heparin prevents antigen-induced airway hyperresponsiveness: interference with IP3-mediated mast cell degranulation? J. Appl. Physiol. 76:893-901.
24. Boushy, H. A., M. J. Holtzman, J. R. Sheller, and J. A. Nadel. 1980. Bronchial hyperreactivity. Am. Rev. Respir. Dis. 121:389-413.
25. Crockcroft, D. W., and K. Y. Murdock. 1987. Comparative effects of inhaled salbutamol, sodium cromoglycate and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses and increased bronchial responsiveness to histamine. J. Allergy Clin. Immunol. 79:734-740.
26. Laurent, T. C., A. Tengblad, L. Thunberg, M. Höök, and U. Lindahl. 1978. The molecular-weight-dependence of the anti-coagulant activity of heparin. Biochem. J. 175:691-701.
27. Martinez-Salas, J., R. Mendelssohn, W. M. Abraham, B. Hsiao, and T. Ahmed. Inhibition of antigen-induced bronchoconstriction and airway hyperresponsiveness by low-molecular weight heparins: molecular weight dependence. J. Appl. Physiol. (In press)
28. Ahmed, T., J. D'Brot, W. M. Abraham, J. Lucio, R. Mendelssohn, M. J. Robinson, S. Shakir, and B. SanPedro. 1996. Heterogeneity of allergic airway responses in sheep: differences in signal transduction? Am. J. Respir. Crit. Care Med. 154:843-849.
29. Ahmed, T., C. Campo, M. K. Abraham, J. F. Molinari, W. M. Abraham, D. Ashkin, T. Syriste, L. O. Andersson, C. M. Svahn, and T. Ahmed. 1997. Inhibition of antigen-induced bronchoconstriction, airway hyperresponsiveness and mast cell degranulation by a nonanticoagulant heparin: comparison with a low molecular weight heparin. Am. J. Respir. Crit. Care Med. 155:1848-1855.
30. Abraham, W. M., M. K. Abraham, and T. Ahmed. 1996. Protective effect of heparin on immunologically induced tracheal smooth muscle contraction in vitro. Int. Arch. Allergy Immunol. 110:79-84.
31. 2+ influx through receptor-mediated activation of nonspecific cation channels in mast cells. Proc. Natl. Acad. Sci. U.S.A. 90:3068-3072.
32. Tones, M. A., M. D. Bootman, B. F. Higgins, D. A. Lane, G. F. Pay, and U. Lindahl. 1989. The effect of heparin on the inositol 1,4,5-trisphosphate receptor in rat liver microsomes: dependence on sulphate content and chain length. FEBS Lett. 252:105-108.
33. Fareed, J., J. M. Walenga, D. Hoppensteadt, A. Racanelli, and E. Coyne. 1989. Chemical and biological heterogeneity in low molecular weight heparins: implications for clinical use and standardization. Semin. Thromb. Hemost. 15:440-463.
34. Barzu, T., P. Molho, G. Tobelem, M. Petitou, and J. Caen. 1985. Binding and endocytosis of heparin by human endothelial cells in culture. Biochim. Biophys. Acta 845:196-203.
35. Ahmed, T., T. Syriste, J. Lucio, W. M. Abraham, M. Robinson, and J. D'Brot. 1993. Inhibition of antigen-induced airway and cutaneous responses by heparin: a pharmacodynamic study. J. Appl. Physiol. 74:1492-1498.
36. Garrigo, J., I. Danta, and T. Ahmed. 1996. Time course of the protective effect of inhaled heparin on exercise-induced asthma. Am. J. Respir. Crit. Care Med. 153:1702-1707.